Last reviewed · How we verify

NCT05912283

Evaluation of 2 Synthetic Nitrile Male Condoms Compared to a Standard Latex Male Condom

Completed NA Last updated 28 May 2024
What this trial tests

NA trial testing Synthetic Nitrile Condoms (53mm) in Sexually Transmitted Diseases in 600 participants. Completed in 31 January 2024.

Timeline
2 June 2023
Primary endpoint
31 January 2024
31 January 2024

Quick facts

Lead sponsorKarex Industries Sdn. Bhd.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposeprevention
Enrollment600
Start date2 June 2023
Primary completion31 January 2024
Estimated completion31 January 2024
Sites3 locations across South Africa, United States

Drugs / interventions tested

Conditions studied

Sponsor

Karex Industries Sdn. Bhd.

Who can join

Adults 18 to 45, any sex, with Sexually Transmitted Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-site, randomised 3-period cross-over trial evaluating the functional performance of two synthetic nitrile male condoms against a control latex male condom.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sexually Transmitted Diseases

Currently open trials in the same condition.

Other Karex Industries Sdn. Bhd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05912283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing